Gilead Antiviral Drug Shows the Most Potential for COVID-19, Says WHO Official

Gilead Sciences (NASDAQ: GILD) received a vote of confidence from the World Health Organization on Monday when a WHO official said that its experimental COVID-1) drug shows great potential.